Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Ackermans & van Haaren NV is a diversified holding company headquartered in Antwerp, Belgium. It focuses on long-term investments in a select portfolio of companies with significant growth potential across international markets. The group operates primarily in five core sectors: Marine Engineering & Contracting through DEME, a leading dredging and offshore specialist, and CFE, a construction and real estate development firm; Private Banking via Delen Private Bank, an independent asset manager active in Belgium, the Netherlands, and the UK through JM Finn, and Bank Van Breda, serving entrepreneurs and liberal professions; Real Estate & Senior Care with Nextensa, an integrated real estate platform; Energy & Resources featuring SIPEF, an agro-industrial player in tropical agriculture; and Growth Capital, targeting promising ventures in various industries. Ackermans & van Haaren NV acts as a strategic partner to family businesses and management teams, fostering sustainable growth and market leadership through active ownership and diversification.
€287.80
€2.40 (-0.83%)
EOD Jun 23, 2026 · Twelve Data
10.43% operating margin is respectable but not wide. ROIC at 2.96%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue declined 1.4% YoY. The question is whether this is cyclical or a structural shift.
Free cash flow declined 51% versus the prior year, cash generation momentum has weakened. Net debt of €8.25B represents 15.4x FCF, leverage limits flexibility.
12.1x earnings, 17.6x FCF. The multiple is below average. Either the market is pricing in deterioration you should investigate, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€5.96B
▼ -1.4% YoY
Net Income (TTM)
€779M
▲ +29.1% YoY
Op. Margin
10.43%
▲ +1.0pp YoY
ROIC
2.96%
▲ +0.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€536M
▼ -51.3% YoY
Op. Cash Flow (TTM)
€536M
▼ -51.3% YoY
Net Debt
€8.25B
Cash & Equiv.
€2.20B
3Y CAGR: +10.6%
3Y CAGR: +38.4%
Continue Research
At a P/E of 12.1 and a price-to-free-cash-flow of 17.6, Ackermans & van Haaren NV (ACKB.XBRU) trades above a two-stage DCF intrinsic value of about €49.58 per share, so at €287.80 the stock looks overvalued (82.8% above estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Ackermans & van Haaren NV scores 76/100 on Intrinsiqq's quality scorecard (a solid business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 1.3%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about €49.58 per share for ACKB.XBRU, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around €37.19. At today's €287.80, that puts the stock about 82.8% above estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Ackermans & van Haaren NV scores 76 out of 100 on Intrinsiqq's quality score, passing 6 of 8 checks, which makes it a solid business on these measures. Recent fundamentals include a 10.4% operating margin and a 3.0% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full check-by-check breakdown is on the quality scorecard.
Yes, Ackermans & van Haaren NV pays a regular dividend of about €3.81 per share per year (typically in quarterly installments), a yield of roughly 1.3% at the current price. That is a payout ratio of about 16.0% of earnings, so the dividend is amply covered by earnings. Ackermans & van Haaren NV has grown the dividend at roughly 12.4% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For ACKB.XBRU's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. ACKB.XBRU currently trades above its estimated intrinsic value and scores 76/100 on quality (solid). It also yields about 1.3%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.